Dose-dependent Effect of Rosuvastatin on Long-term Clinical Outcomes After PCI

NCT02859480 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease
Coronary Disease
Cardiovascular Diseases

Interventions

DRUG: Rosuvastatin 5mg
DRUG: Rosuvastatin 20mg

Sponsor

Korea University Anam Hospital

Collaborators

[object Object]